Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Nature
|
January 3, 1975
Dissociation of Factor VIII-related antigen into subunits
D E Austen, M Carey, M A Howard
Nature
|
June 20, 1985
Expression of active human clotting factor IX from recombinant DNA clones in mammalian cells
D S Anson, D E Austen, G G Brownlee
British Journal of Haematology
|
August 1, 1992
Subcutaneous injection of factor IX for the treatment of haemophilia B
A J Gerrard, D E Austen, G G Brownlee
Lancet (London, England)
|
November 21, 1981
Factor VIII concentrates: What the label says
D E Austen, I R Rhymes, C R Rizza
British Journal of Haematology
|
December 1, 1996
Recombinant factor IX secreted by transduced human keratinocytes is biologically active
A J Gerrard, D E Austen, G G Brownlee
Thrombosis and Haemostasis
|
February 26, 1982
A comparison of the Bethesda and New Oxford methods of factor VIII antibody assay
D E Austen, K Lechner, C R Rizza, et al.
Protein Engineering
|
September 1, 1994
Protein engineering of the hydrophobic domain of human factor IX
P E Hughes, P A Handford, D E Austen, et al.
British Journal of Haematology
|
August 1, 1972
The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs
R Biggs, D E Austen, K W Denson, et al.
British Journal of Haematology
|
August 1, 1972
The mode of action of antibodies which destroy factor VIII. I. Antibodies which have second-order concentration graphs
R Biggs, D E Austen, K W Denson, et al.
British Journal of Haematology
|
December 24, 1997
Clotting factor IX levels in C/EBP alpha knockout mice
N Davies, D E Austen, M D Wilde, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Nature
|
January 3, 1975
Dissociation of Factor VIII-related antigen into subunits
D E Austen, M Carey, M A Howard
Nature
|
June 20, 1985
Expression of active human clotting factor IX from recombinant DNA clones in mammalian cells
D S Anson, D E Austen, G G Brownlee
British Journal of Haematology
|
August 1, 1992
Subcutaneous injection of factor IX for the treatment of haemophilia B
A J Gerrard, D E Austen, G G Brownlee
Lancet (London, England)
|
November 21, 1981
Factor VIII concentrates: What the label says
D E Austen, I R Rhymes, C R Rizza
British Journal of Haematology
|
December 1, 1996
Recombinant factor IX secreted by transduced human keratinocytes is biologically active
A J Gerrard, D E Austen, G G Brownlee
Thrombosis and Haemostasis
|
February 26, 1982
A comparison of the Bethesda and New Oxford methods of factor VIII antibody assay
D E Austen, K Lechner, C R Rizza, et al.
Protein Engineering
|
September 1, 1994
Protein engineering of the hydrophobic domain of human factor IX
P E Hughes, P A Handford, D E Austen, et al.
British Journal of Haematology
|
August 1, 1972
The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs
R Biggs, D E Austen, K W Denson, et al.
British Journal of Haematology
|
August 1, 1972
The mode of action of antibodies which destroy factor VIII. I. Antibodies which have second-order concentration graphs
R Biggs, D E Austen, K W Denson, et al.
British Journal of Haematology
|
December 24, 1997
Clotting factor IX levels in C/EBP alpha knockout mice
N Davies, D E Austen, M D Wilde, et al.
Page
of 3